A review paper published last year in European Journal of Medicinal Chemistry characterized Myc as the “oncogene from ...

A major 2018 study by the Cancer Genome Atlas Program, led by researchers in the US, found that 10 key biochemical pathways are involved in activating cancers, including EGFR/RAS, Wnt, Myc ...

Some non-small-cell lung cancers (NSCLC) have changes in a gene called EGFR. If your NSCLC has these mutations, your doctor likely will recommend treatment with targeted therapies that block EGFR.

Objective Many societies recommend using estimated glomerular filtration rate (eGFR) rather than serum creatinine (sCr) to determine metformin eligibility. We examined the potential impact of ...

Lazertinib is an oral, highly selective, third-generation EGFR tyrosine kinase inhibitor that can penetrate the brain, and amivantamab is a bispecific antibody targeting EGFR and mesenchymal ...